![](/img/cover-not-exists.png)
PP 35 Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
D. Christoph, T. Gauler, M. Engelhard, D. Theegarten, C. Poettgen, R. Hepp, M. Schuler, F. Hirsch, W. Eberhardt, J. WohlschlaegerVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)72641-7
File:
PDF, 55 KB
english, 2011